Molecular Progress of Cardiovascular and Metabolic Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 February 2026 | Viewed by 65
Special Issue Editor
Interests: gene therapy; rare disease; advanced therapies; gene expression
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue “Molecular Progress of Cardiovascular and Metabolic Disease” in the International Journal of Molecular Sciences aims to gather cutting-edge research advancing the understanding of the molecular mechanisms underlying the cardiometabolic continuum, from endothelial dysfunction to heart failure and metabolic complications.
We welcome studies on integrated and single-cell omics, systems biology, and signaling networks; immunometabolism and inflammation; oxidative stress and mitochondrial function; epigenetics and non-coding RNAs; microbiota and the gut–heart axis; and energy remodeling in the myocardium, adipose tissue, and skeletal muscle. Contributions exploring inter-organ crosstalk and sex- or age-specific differences are encouraged. Translational and preclinical studies focusing on biomarker and therapeutic target discovery, high-throughput screening platforms, in vitro/in vivo models, and artificial intelligence applications for risk stratification and precision medicine are of particular interest.
We invite original articles, reviews, and method papers with reproducible results, FAIR-compliant datasets, and clear clinical implications.
Dr. Ilenia Calcaterra
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiometabolic continuum
- endothelial dysfunction
- heart failure
- metabolic complications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
